-
1
-
-
33748652419
-
What is the right dose? The elusive optimal biologic dose in phase I clinical trials
-
Adjei, A.A. What is the right dose? The elusive optimal biologic dose in phase I clinical trials. J. Clin. Oncol. 24, 4054-4055 (2006).
-
(2006)
J. Clin. Oncol.
, vol.24
, pp. 4054-4055
-
-
Adjei, A.A.1
-
2
-
-
9144247189
-
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
-
Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178 (2004).
-
(2004)
Nature
, vol.432
, pp. 173-178
-
-
Soutschek, J.1
-
3
-
-
33751099034
-
RNAi therapeutics: A potential new class of pharmaceutical drugs
-
Bumcrot, D., Manoharan, M., Koteliansky, V. & Sah, D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711-719 (2006).
-
(2006)
Nat. Chem. Biol.
, vol.2
, pp. 711-719
-
-
Bumcrot, D.1
Manoharan, M.2
Koteliansky, V.3
Sah, D.W.4
-
5
-
-
84894414494
-
Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system
-
Buckley, D.L. & Crews, C.M. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system. Angew. Chem. Int. Edn. Engl. 53, 2312-2330 (2014).
-
(2014)
Angew. Chem. Int. Edn. Engl.
, vol.53
, pp. 2312-2330
-
-
Buckley, D.L.1
Crews, C.M.2
-
6
-
-
0035902475
-
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
-
Sakamoto, K.M. et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. USA 98, 8554-8559 (2001).
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 8554-8559
-
-
Sakamoto, K.M.1
-
7
-
-
55549137044
-
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
-
Schneekloth, A.R., Pucheault, M., Tae, H.S. & Crews, C.M. Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics. Bioorg. Med. Chem. Lett. 18, 5904-5908 (2008).
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 5904-5908
-
-
Schneekloth, A.R.1
Pucheault, M.2
Tae, H.S.3
Crews, C.M.4
-
8
-
-
1642343326
-
Chemical genetic control of protein levels: Selective in vivo targeted degradation
-
Schneekloth, J.S. Jr. et al. Chemical genetic control of protein levels: selective in vivo targeted degradation. J. Am. Chem. Soc. 126, 3748-3754 (2004).
-
(2004)
J. Am. Chem. Soc.
, vol.126
, pp. 3748-3754
-
-
Schneekloth, J.S.1
-
9
-
-
84878429220
-
Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
-
Hines, J., Gough, J.D., Corson, T.W. & Crews, C.M. Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs. Proc. Natl. Acad. Sci. USA 110, 8942-8947 (2013).
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 8942-8947
-
-
Hines, J.1
Gough, J.D.2
Corson, T.W.3
Crews, C.M.4
-
10
-
-
0037035851
-
Structure of an HIF-1α-pVHL complex: Hydroxyproline recognition in signaling
-
Min, J.H. et al. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889 (2002).
-
(2002)
Science
, vol.296
, pp. 1886-1889
-
-
Min, J.H.1
-
11
-
-
18444368709
-
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL
-
Hon, W.C. et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975-978 (2002).
-
(2002)
Nature
, vol.417
, pp. 975-978
-
-
Hon, W.C.1
-
12
-
-
57349130557
-
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
-
Rodriguez-Gonzalez, A. et al. Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer. Oncogene 27, 7201-7211 (2008).
-
(2008)
Oncogene
, vol.27
, pp. 7201-7211
-
-
Rodriguez-Gonzalez, A.1
-
13
-
-
41149156498
-
Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: A potential tool for chemoprevention
-
Puppala, D., Lee, H., Kim, K.B. & Swanson, H.I. Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: a potential tool for chemoprevention. Mol. Pharmacol. 73, 1064-1071 (2008).
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 1064-1071
-
-
Puppala, D.1
Lee, H.2
Kim, K.B.3
Swanson, H.I.4
-
14
-
-
84862170982
-
Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist
-
Itoh, Y. et al. Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist. Bioorg. Med. Chem. Lett. 22, 4453-4457 (2012).
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 4453-4457
-
-
Itoh, Y.1
-
15
-
-
84886786805
-
Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells
-
Okuhira, K. et al. Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells. Cancer Sci. 104, 1492-1498 (2013).
-
(2013)
Cancer Sci.
, vol.104
, pp. 1492-1498
-
-
Okuhira, K.1
-
16
-
-
44049087791
-
Small molecules destabilize cIAP1 by activating autoubiquitylation
-
Sekine, K. et al. Small molecules destabilize cIAP1 by activating autoubiquitylation. J. Biol. Chem. 283, 8961-8968 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 8961-8968
-
-
Sekine, K.1
-
17
-
-
84858201095
-
Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1alpha interaction
-
Buckley, D.L. et al. Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1alpha interaction. J. Am. Chem. Soc. 134, 4465-4468 (2012).
-
(2012)
J. Am. Chem. Soc.
, vol.134
, pp. 4465-4468
-
-
Buckley, D.L.1
-
18
-
-
84937534394
-
Compounds and methods for the inhibition of vcb e3 ubiquitin ligase
-
Patent
-
Crews, C.M. et al. Compounds and methods for the inhibition of vcb e3 ubiquitin ligase. Patent PCT/US2013/021141 (2013).
-
(2013)
-
-
Crews, C.M.1
-
19
-
-
84868522211
-
Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1alpha
-
Buckley, D.L. et al. Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1alpha. Angew. Chem. Int. Edn Engl. 51, 11463-11467 (2012).
-
(2012)
Angew. Chem. Int. Edn Engl.
, vol.51
, pp. 11463-11467
-
-
Buckley, D.L.1
-
20
-
-
79957944105
-
Estrogen related receptors (ERRs): A new dawn in transcriptional control of mitochondrial gene networks
-
Eichner, L.J. & Giguere, V. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11, 544-552 (2011).
-
(2011)
Mitochondrion
, vol.11
, pp. 544-552
-
-
Eichner, L.J.1
Giguere, V.2
-
21
-
-
79851480621
-
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents
-
Patch, R.J. et al. Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents. J. Med. Chem. 54, 788-808 (2011).
-
(2011)
J. Med. Chem.
, vol.54
, pp. 788-808
-
-
Patch, R.J.1
-
22
-
-
84961289586
-
RIP kinases: Key decision makers in cell death and innate immunity
-
Humphries, F., Yang, S., Wang, B. & Moynagh, P.N. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ. 22, 225-236 (2015).
-
(2015)
Cell Death Differ.
, vol.22
, pp. 225-236
-
-
Humphries, F.1
Yang, S.2
Wang, B.3
Moynagh, P.N.4
-
23
-
-
17944372335
-
CARD15 mutations in Blau syndrome
-
Miceli-Richard, C. et al. CARD15 mutations in Blau syndrome. Nat. Genet. 29, 19-20 (2001).
-
(2001)
Nat. Genet.
, vol.29
, pp. 19-20
-
-
Miceli-Richard, C.1
-
24
-
-
19944431022
-
Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: Common genetic etiology with Blau syndrome
-
Kanazawa, N. et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105, 1195-1197 (2005).
-
(2005)
Blood
, vol.105
, pp. 1195-1197
-
-
Kanazawa, N.1
-
25
-
-
0033621047
-
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
-
Meng, L. et al. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 96, 10403-10408 (1999).
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 10403-10408
-
-
Meng, L.1
-
26
-
-
34249826059
-
Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide
-
Windheim, M., Lang, C., Peggie, M., Plater, L.A. & Cohen, P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J. 404, 179-190 (2007).
-
(2007)
Biochem. J.
, vol.404
, pp. 179-190
-
-
Windheim, M.1
Lang, C.2
Peggie, M.3
Plater, L.A.4
Cohen, P.5
-
27
-
-
79956322553
-
Global quantification of mammalian gene expression control
-
Schwanhäusser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337-342 (2011).
-
(2011)
Nature
, vol.473
, pp. 337-342
-
-
Schwanhäusser, B.1
-
28
-
-
84876720161
-
A comprehensive mathematical model for three-body binding equilibria
-
Douglass, E.F. Jr., Miller, C.J., Sparer, G., Shapiro, H. & Spiegel, D.A. A comprehensive mathematical model for three-body binding equilibria. J. Am. Chem. Soc. 135, 6092-6099 (2013).
-
(2013)
J. Am. Chem. Soc.
, vol.135
, pp. 6092-6099
-
-
Douglass, E.F.1
Miller, C.J.2
Sparer, G.3
Shapiro, H.4
Spiegel, D.A.5
-
29
-
-
0034641615
-
Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
-
Kamura, T. et al. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA 97, 10430-10435 (2000).
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 10430-10435
-
-
Kamura, T.1
-
30
-
-
0033607291
-
Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
-
Iwai, K. et al. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96, 12436-12441 (1999).
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 12436-12441
-
-
Iwai, K.1
-
31
-
-
35349008456
-
Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790
-
Lanvin, O., Bianco, S., Kersual, N., Chalbos, D. & Vanacker, J.M. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J. Biol. Chem. 282, 28328-28334 (2007).
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 28328-28334
-
-
Lanvin, O.1
Bianco, S.2
Kersual, N.3
Chalbos, D.4
Vanacker, J.M.5
-
32
-
-
77949874846
-
Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates
-
Lee, J., Udugamasooriya, D.G., Lim, H.S. & Kodadek, T. Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates. Nat. Chem. Biol. 6, 258-260 (2010).
-
(2010)
Nat. Chem. Biol.
, vol.6
, pp. 258-260
-
-
Lee, J.1
Udugamasooriya, D.G.2
Lim, H.S.3
Kodadek, T.4
-
33
-
-
0035347260
-
Induction of HIF-1a in response to hypoxia is instantaneous
-
Jewell, U.R. Induction of HIF-1a in response to hypoxia is instantaneous. FASEB J. 15, 1312-1314 (2001).
-
(2001)
FASEB J.
, vol.15
, pp. 1312-1314
-
-
Jewell, U.R.1
-
34
-
-
84892188402
-
Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif
-
Guo, Y. et al. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif. Nature 505, 229-233 (2014).
-
(2014)
Nature
, vol.505
, pp. 229-233
-
-
Guo, Y.1
-
35
-
-
84877615286
-
A call to ARMs: The promise of immunomodulatory small molecules
-
Spiegel, D.A. A call to ARMs: the promise of immunomodulatory small molecules. Expert Rev. Clin. Pharmacol. 6, 223-225 (2013).
-
(2013)
Expert Rev. Clin. Pharmacol.
, vol.6
, pp. 223-225
-
-
Spiegel, D.A.1
-
36
-
-
69249218864
-
Design, synthesis and selection of DNA-encoded small-molecule libraries
-
Clark, M.A. et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat. Chem. Biol. 5, 647-654 (2009).
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 647-654
-
-
Clark, M.A.1
-
37
-
-
84871581868
-
A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities
-
Noblin, D.J. et al. A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities. ACS Chem. Biol. 7, 2055-2063 (2012).
-
(2012)
ACS Chem. Biol.
, vol.7
, pp. 2055-2063
-
-
Noblin, D.J.1
-
38
-
-
33646587681
-
A robust small-molecule microarray platform for screening cell lysates
-
Bradner, J.E. et al. A robust small-molecule microarray platform for screening cell lysates. Chem. Biol. 13, 493-504 (2006).
-
(2006)
Chem. Biol.
, vol.13
, pp. 493-504
-
-
Bradner, J.E.1
-
39
-
-
34948875686
-
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
-
Bantscheff, M. et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25, 1035-1044 (2007).
-
(2007)
Nat. Biotechnol.
, vol.25
, pp. 1035-1044
-
-
Bantscheff, M.1
-
40
-
-
79952396960
-
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
-
Bantscheff, M. et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265 (2011).
-
(2011)
Nat. Biotechnol.
, vol.29
, pp. 255-265
-
-
Bantscheff, M.1
-
41
-
-
84906260520
-
Chemoproteomics reveals time-dependent binding of histone deacetylase inhibitors to endogenous repressor complexes
-
Becher, I. et al. Chemoproteomics reveals time-dependent binding of histone deacetylase inhibitors to endogenous repressor complexes. ACS Chem. Biol. 9, 1736-1746 (2014).
-
(2014)
ACS Chem. Biol.
, vol.9
, pp. 1736-1746
-
-
Becher, I.1
-
42
-
-
84861329091
-
A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation
-
Bergamini, G. et al. A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation. Nat. Chem. Biol. 8, 576-582 (2012).
-
(2012)
Nat. Chem. Biol.
, vol.8
, pp. 576-582
-
-
Bergamini, G.1
-
43
-
-
84865454296
-
High-resolution enabled TMT 8-plexing
-
Werner, T. et al. High-resolution enabled TMT 8-plexing. Anal. Chem. 84, 7188-7194 (2012).
-
(2012)
Anal. Chem.
, vol.84
, pp. 7188-7194
-
-
Werner, T.1
-
44
-
-
78651340521
-
Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells
-
Kruse, U. et al. Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells. Leukemia 25, 89-100 (2011).
-
(2011)
Leukemia
, vol.25
, pp. 89-100
-
-
Kruse, U.1
-
45
-
-
84897508532
-
Ion coalescence of neutron encoded TMT 10-plex reporter ions
-
Werner, T. et al. Ion coalescence of neutron encoded TMT 10-plex reporter ions. Anal. Chem. 86, 3594-3601 (2014).
-
(2014)
Anal. Chem.
, vol.86
, pp. 3594-3601
-
-
Werner, T.1
-
46
-
-
82555185589
-
Delayed fragmentation and optimized isolation width settings for improvement of protein identification and accuracy of isobaric mass tag quantification on Orbitrap-type mass spectrometers
-
Savitski, M.M. et al. Delayed fragmentation and optimized isolation width settings for improvement of protein identification and accuracy of isobaric mass tag quantification on Orbitrap-type mass spectrometers. Anal. Chem. 83, 8959-8967 (2011).
-
(2011)
Anal. Chem.
, vol.83
, pp. 8959-8967
-
-
Savitski, M.M.1
-
47
-
-
77956836941
-
Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays
-
Savitski, M.M. et al. Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays. J. Am. Soc. Mass Spectrom. 21, 1668-1679 (2010).
-
(2010)
J. Am. Soc. Mass Spectrom.
, vol.21
, pp. 1668-1679
-
-
Savitski, M.M.1
-
48
-
-
84881163875
-
Measuring and managing ratio compression for accurate iTRAQ/TMT quantification
-
Savitski, M.M. et al. Measuring and managing ratio compression for accurate iTRAQ/TMT quantification. J. Proteome Res. 12, 3586-3598 (2013).
-
(2013)
J. Proteome Res.
, vol.12
, pp. 3586-3598
-
-
Savitski, M.M.1
-
49
-
-
70349624519
-
Proteomics strategy for quantitative protein interaction profiling in cell extracts
-
Sharma, K. et al. Proteomics strategy for quantitative protein interaction profiling in cell extracts. Nat. Methods 6, 741-744 (2009).
-
(2009)
Nat. Methods
, vol.6
, pp. 741-744
-
-
Sharma, K.1
-
50
-
-
77954660028
-
Implementation and evaluation of relative and absolute quantification in shotgun proteomics with label-free methods
-
Grossmann, J. et al. Implementation and evaluation of relative and absolute quantification in shotgun proteomics with label-free methods. J. Proteomics 73, 1740-1746 (2010).
-
(2010)
J. Proteomics
, vol.73
, pp. 1740-1746
-
-
Grossmann, J.1
-
51
-
-
31644446949
-
Absolute quantification of proteins by LCMSE: A virtue of parallel ms acquisition
-
Silva, J.C., Gorenstein, M.V., Li, G.-Z., Vissers, J.P.C. & Geromanos, S.J. Absolute quantification of proteins by LCMSE: a virtue of parallel ms acquisition. Mol. Cell. Proteomics 5, 144-156 (2006).
-
(2006)
Mol. Cell. Proteomics
, vol.5
, pp. 144-156
-
-
Silva, J.C.1
Gorenstein, M.V.2
Li, G.-Z.3
Vissers, J.P.C.4
Geromanos, S.J.5
-
52
-
-
57449099865
-
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
-
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
-
(2008)
Nat. Biotechnol.
, vol.26
, pp. 1367-1372
-
-
Cox, J.1
Mann, M.2
-
53
-
-
0035829361
-
Controlling the false discovery rate in behavior genetics research
-
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279-284 (2001).
-
(2001)
Behav. Brain Res.
, vol.125
, pp. 279-284
-
-
Benjamini, Y.1
Drai, D.2
Elmer, G.3
Kafkafi, N.4
Golani, I.5
|